Item 8.01 Other Events.

On July 20, 2009, A.P. Pharma, Inc. announced that the U.S. Food and Drug Administration (the "FDA") has accepted for review the New Drug Application for APF530 for the potential treatment of chemotherapy-induced nausea and vomiting. Based on the Prescription Drug User Fee Act, the FDA has issued an action date of March 18, 2010.

The foregoing description is qualified in its entirety by reference to our press release dated July 20, 2009, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference.

ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Document Description
99.1 Press Release issued on July 20, 2009.